Ideally, future studies examining predictive value of the LHCGR should have increased sample size and combine information about LHCGR expression in prostatic tissue with serum levels of LHCGR to determine whether it is a marker of LHCGR abundance in the tumor or a proxy for something else. This evidence concerns the gene LHCGR and neoplasm.